PTGS2 and colorectal cancer: This report shows that eltanexor effectively limits cell viability in colorectal cancer cells, reduces the chemoprevention target COX-2, and impairs the transcriptional activity of a paramount signaling pathway in colorectal cancer, Wnt/β-catenin signaling.